the aid library

Resource Effective Strategies to Prevent and Treat Cardiovascular Disease

Schwalm, J.; McKee, M.; Huffman, M. et al. Circulation (2016) CC

Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the... more

External Link

Achieving universal electrification of rural healthcare facilities in sub-Saharan Africa with decentralized renewable energy technologies

Moner-Girona, M.; et al. (2021) CC

Joule 5, 2687–2714 October 20, 2021 Cell Press

External Link

Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future Directions

Sallam, M.; A.O.Al-Kathib, K.S.Al-Mazhoum, et al. Dove Press (2025) CC

Clinical Pharmacology: Advances and Applications, 2025:17 29–47

Download (804)

View PDF (267)

Manual para el Diagnóstico Bacteriológico de Tuberculosis

Sequeira, M.D.; Barrera l., Imaz M. S., et al. (2016) CC

Parte I - Baciloscopía

Download (731)

View PDF (723)

Review of Tuberculosis Prevention, Control and Care in Azerbaijan (Russian edition)

M. Dara, O. Gozalov, O. Javadli, et al. World Health Organization Europe (2013) C_WHO

11-17 April 2012 Оценка профилактики и борьбы с туберкулезом и противотуберкулезной помощи в Азербайджане 11–17 апреля 2012 г.

Download (315)

View PDF (318)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download (560)

View PDF (660)

Mobile Populations

M. Smelyanskaya, J. Duncan (The Focus Group Consulting); C. Daniels, et al. Stop TB Partnership; UNOPS; END TB (2015) C1

Key populations brief.

Download (169)

View PDF (175)

Individual- and Facility-Level Factors Associated with Facility Testing among Men in Malawi: Findings from a Representative Community Survey

Balakasi, K.; Nichols, B. E.; Mphande, M.; et al. (2021) CC2

Men are underrepresented in HIV testing services throughout sub-Saharan Africa. HIV testing is critical to achieve the UNAIDS 95-95-95 goals, as it is the first entry point to HIV care. In Malawi, an estimated 14% of HIV positive men are undiagnosed, while only 6% of HIV positive women remain undiag... more

Download (344)

View PDF (495)

Trastorno por déficit de atención con hiperactividad

T. S. Moriyama; A. J. M. Cho; R. E. Verin; et al. IACAPAP (2017) C2

Trastornos externalizantes Capítulo D.1 Edición: Matías Irarrázaval & Andrés Martín Traducción: Fernanda Prieto Tagle, Marta García Acuña

External Link

Achieving UNAIDS 90-90-90 targets for pregnant and postpartum women in sub-Saharan Africa: progress, gaps and research needs

L. L. Abuogi; J. M. Humphrey; C. Mpody, et al. Journal of Virus Eradication (2018) CC

Journal of Virus Eradication 2018; 4 (Supplement 2): 33–39

Download (464)

View PDF (712)

Attention deficit hyperactivity disorder (Russian version edited by O Dolenko, D Martsenkovskyi) Расстройство дефицита внимания и гиперактивности

Moriyama TS, Cho AJM, Verin RE et al. International Association for Child and Adolescent Psychiatry and Allied Professions (2012) C1

This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to describe the best treatments and pract... more

Download (350)

View PDF (466)

мигранты (Mobile Russian edition)

FG Consulting Group, C. Daniels, C. Smyth et al. UNOPS, Stop TB Partnership et al. (2019) C1

Hесмотря на многочисленные международные договоры и обязательства по защите прав мигрантов в области здравоохранения, эта ключевая затронутая группа населения п�... more

Download (360)

View PDF (534)

Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans

Ojji, D.B.; et al. (2019) C1

N Engl J Med 2019;380:2429-39.DOI: 10.1056/NEJMoa1901113

Download (292)

View PDF (567)

Pharmaceutical Waste Management: A Review

Rajbongshi, S.; et al. (2016) C1

European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206 This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.

Download (1274)

View PDF (2132)

Support Services for Survivors of Ebola Virus Disease — Sierra Leone, 2014

Seung Hee Lee-Kwan, et al. (2014)

MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206

External Link

Community-Centered Responses to Ebola in Urban Liberia: The View from Below

Sharon Alane Abramowitz, et al. (2014)

External Link

Treatment Gap for Anxiety Disorders is Global: Results of the World Mental Health Surveys in 21 countries

Alonso, J.; et al. (2018) CC

Depress Anxiety. 2018 March ; 35(3): 195–208. doi:10.1002/da.22711.

External Link

Evidence-based guidelines for supportive care of patients with Ebola virus disease

Lamontagne, F.; R.A. Fowler, N.K. Adhikari, et al. (2018) C2

Lancet 2018; 391: 700–08

External Link

Climate Solutions Double as Health Interventions

Mailloux, N.A. et al. (2021) CC

Int. J. Environ. Res. Public Health 2021, 18(24), 13339; https://doi.org/10.3390/ijerph182413339 The climate crisis threatens to exacerbate numerous climate-sensitive health risks, including heatwave mortality, malnutrition from reduced crop yields, water- and vector-borne infectious diseases, and... more